01
Peptides, Proteins and Biologics
Microneedle feasibility depends on target dose, molecular stability, formulation compatibility, delivery efficiency and the intended product pathway.
Start a ProjectEN / 中文EN
🇨🇳 中文EN English
Menu
HomeManufacturingContactStart a Project
Solutions
View all SolutionsDrug Delivery CRO/CDMOMedical Device CDMOSkincare ODM/OEMMicroneedle Essence OilCapabilities
View all CapabilitiesFeasibility AssessmentFormulation DevelopmentProcess DevelopmentAnalytical EvaluationPilot Scale-UpClinical-Stage SupportCommercial ManufacturingMold & Forming CapabilitiesTechnologies
View all TechnologiesDissolving MicroneedlesCoated MicroneedlesSwelling MicroneedlesKnowledge CenterAbout
View all AboutCompanyQualifications & HonorsResearch & Intellectual PropertyMilestonesNews & InsightsApplication-led evaluation for microneedle product development
Microneedle Delivery Applications
Explore microneedle delivery considerations for peptides, proteins, biologics, vaccines, metabolic programs, dermatology, pain management and long-acting delivery.PAYLOADS AND APPLICATIONS
Microneedle Development Across Multiple Research Areas
Explore formulation, delivery, evaluation and manufacturing considerations across different payload and application categories.
Request a Feasibility AssessmentPeptides & Proteins
Project-specific delivery, formulation and development considerations.
Explore Peptides & Proteins →Biologics
Project-specific delivery, formulation and development considerations.
Explore Biologics →Vaccines
Project-specific delivery, formulation and development considerations.
Explore Vaccines →Metabolic & GLP-1 Research
Project-specific delivery, formulation and development considerations.
Explore Metabolic & GLP-1 Research →Dermatology
Project-specific delivery, formulation and development considerations.
Explore Dermatology →Pain Management
Project-specific delivery, formulation and development considerations.
Explore Pain Management →Long-Acting Delivery
Project-specific delivery, formulation and development considerations.
Explore Long-Acting Delivery →02
Vaccines and Intradermal Delivery
Intradermal delivery programs require application-specific assessment of antigen stability, loading strategy, delivery performance and manufacturing controls.
03
Metabolic and GLP-1-Related Research
Programs involving peptide payloads require careful review of dose capacity, stability, release profile and the practical patch design.
04
Dermatology and Pain Management
Localized delivery concepts are assessed against target tissue, intended use, active ingredient properties and regulatory classification.
05
Long-Acting Development Considerations
Sustained-release approaches may involve layered structures, microparticles or implantable microneedle designs and require integrated formulation and process evaluation.
Request an Application Assessment
Send your target product, payload, development stage and cooperation scope to our business development team.
Start a Project